InventisBio and Betta Pharma to Co-Develop Novel Drug for Non-Small Cell Lung Cancer

SHANGHAI, Dec. 28, 2018 /PRNewswire/ -- InventisBio (Shanghai) (hereinafter referred to as "InventisBio") announced today that it has signed a "Collaboration Agreement" with Betta Pharma (hereinafter referred to as "Betta Pharma"). Under this agreement, InventisBio will out-license...

from PR Newswire: https://prn.to/2ETIBFb